INTRODUCTION
============

Chronic kidney disease (CKD) is recognized as a global health problem ([@B1]). The health and economic burdens of CKD are high. Patients with CKD are at increased risk for cardiovascular disease (CVD) and end-stage renal failure. Adverse changes in nutrition are prevalent with decreasing renal function and are a strong indicator of adverse outcomes in patients with CKD ([@B2]).

Multiple mechanisms are involved in adverse nutritional changes in CKD patients. Poor food intake caused by uremia-induced anorexia alone does not explain adverse nutritional changes. There are additional contributing causes, such as persistent inflammation, acidosis, multiple hormonal disturbance, comorbidities, and physical inactivity ([@B3]). Many studies about nutritional status of CKD patients revealed that wasting and protein-energy abnormalities might be induced by inflammatory processes ([@B2]). Simple malnutrition refers to nutritional abnormalities induced by inadequate nutritional intake, whereas wasting caused by CKD refers to nutritional abnormalities that may be associated with inflammation and cannot be corrected solely by increasing the diet. The International Society of Renal Nutrition and Metabolism (ISRNM) ([@B4]) proposed a common nomenclature and diagnostic criteria for this adverse nutritional status in the context of CKD. Protein-energy wasting (PEW) was proposed to denote concurrent losses in protein and energy stores in CKD patients.

PEW is a strong indicator of adverse outcome and is associated with CVD. Persistent inflammatory processes in CKD could act as links between inflammation, PEW, and CVD. Several studies ([@B5][@B6][@B7][@B8]) have reported that strong interactions exist among inflammatory parameters, nutritional parameters, and CVD in CKD patients.

In this study, we examined the nutritional status of predialysis CKD in adults enrolled in the KoreaN cohort study for Outcome in patients with Chronic Kidney Disease (KNOW-CKD) study. As there was a need for further understanding of nutritional status and associated factors in CKD, we described nutritional status, inflammatory markers, CVD, and other clinical characteristics according to estimated glomerular filtration rate (eGFR) and PEW parameters. We also explored factors associated with PEW in adults with predialysis CKD.

MATERIALS AND METHODS
=====================

Study participants
------------------

The KNOW-CKD study is an ongoing multicenter prospective, observational study of adults with CKD in Korea. The study design was published previously ([@B9]), and is summarized here. Each participating center enrolled a baseline of 2,238 adults with CKD from 2011 to 2015. All enrolled participants were ethnic Korean patients between 20 and 75 years old with predialysis CKD stage 1 to 5, which was staged based on eGFR. Those who had a history of malignancy, liver cirrhosis, advanced heart failure, or who had a single kidney were excluded according to the KNOW-CKD protocol. We included a total of 1,834 participants in the analysis who underwent complete 24-hour urine chemistry, serum high sensitivity C-reactive protein (hs-CRP) concentration measurement, and baseline laboratory tests. All included patients also completed a health questionnaire

PEW parameters and definition
-----------------------------

Using data from the initial KNOW-CKD study, indicators for PEW were created based on the ISRNM diagnostic criteria ([@B4]). An ISRNM expert panel recommended four main categories for diagnosing PEW: biochemical parameter, low body mass, decreased muscle mass, and low protein intake. PEW parameters and diagnostic criteria in this study included the following: 1) Biochemical parameter: serum albumin \< 3.8 g/dL; 2) Body mass: body mass index (BMI) \< 23.0 kg/m^2^; 3) Muscle mass: 24-hour urine creatinine excretion (UCE) \< the sex-specific lower quartile; and 4) Dietary intake: dietary protein intake (DPI) \< 0.6 g/kg/day. Three or more of these indicators must be present for a diagnosis of PEW. Twenty-four-hour urine collection began after the bladder was emptied in the morning and continued for 24 hours, including the last urination the following morning. We excluded patients from whom less than 500 mL/day of urine was collected, because of concerns regarding urine collection errors. UCE and urine urea excretion were measured. UCE was evaluated according to sex. DPI was calculated using the following formula ([@B10][@B11]):

6.25 × (\[24-hour urine urea nitrogen excreted in grams\] + \[weight in kilograms × 0.031 g nitrogen/kg/day\]) + 24-hour urine proteinuria (g/day, if urinary protein loss \> 5 g/day)

Other variables
---------------

Data regarding demographics, medical history, causes of CKD and comorbid conditions were collected at baseline by a well-trained study coordinator using a standardized case report form and protocol. Serum samples were collected at baseline according to our standardized protocol and sent to a central laboratory for measurement. Serum creatinine concentration was measured using an isotope-dilution mass spectrometry-traceable method. eGFR was calculated using the 4-variable Modification of Diet in Renal Disease (MDRD) formula as follows ([@B12]):

eGFR mL/min/1.73 m^2^ = 175 × serum creatinine (mg/dL)^−1.154^ × age^−0.203^ × 0.742 (if female)

Inflammatory marker was investigated by measuring hs-CRP. Inflammation was defined as hs-CRP \> 3 mg/L ([@B13]). A patient was defined as an active smoker if a person currently smoked. Alcohol drinking was defined as having more than 2 times of standard drinking (about one bottle of beer, 14 grams of alcohol)/week. Physical activity for health was defined as more than 150 min/week moderate activity, or 75 min/week vigorous activity, or an equivalent combination according to global recommendations on physical activity for health of World Health Organization ([@B14]). Cardiovascular disease was defined as having medical history of myocardial infarction, heart failure, peripheral vascular disease, or stroke.

Statistical analysis
--------------------

Data were expressed as a percentage for categorical variables and as the mean ± standard deviation (SD) for continuous variables. We used χ^2^ test for categorical variables and the analysis of variance (ANOVA) for continuous variables to show differences in baseline characteristics according to CKD stage and PEW score. The covariates for PEW were selected according to our baseline data and other PEW studies of CKD. In logistic analyses of PEW, the associated factors were expressed as odds ratios (ORs) and 95% confidence intervals (CIs).

All statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS) PASW statistics version 18.0 (IBM, Armonk, NY, USA).

Ethics statement
----------------

The study protocol was approved by the relevant ethics committees, and all participants were informed of their inclusion in this registry. The KNOW-CKD study was supervised by the Korea Centers for Disease Control and Prevention. The design of the present study was approved by Institutional Review Board of the Kangbuk Samsung Hospital (2011-01-076-011).

RESULTS
=======

Nutritional and inflammatory status
-----------------------------------

A total of 1,834 adults with predialysis CKD were included in the study. The mean age was 53.9 ± 12.2 years old, and 60.4% were male. In the study population, 34.5% had diabetes and 96.1% had hypertension.

Characteristics of the patients are shown in [Tables 1](#T1){ref-type="table"} and [2](#T2){ref-type="table"}. Those with an advanced CKD stage tended to have more CVD, lower Total CO~2~, and greater weight loss. Inflammation prevalence and neutrophil percent increased with CKD stage. PEW prevalence was 2.2%, 4.4%, 8.3%, 6.2%, 15.6%, and 24.6% in CKD stage 1, 2, 3a, 3b, 4, and 5, respectively. Patients with an advanced eGFR stages had lower serum albumin, lower UCE, and lower DPI ([Table 1](#T1){ref-type="table"}). Those with more PEW parameters tended to have advanced CKD, diabetes, and CVD. They also had lower TCO~2~, low physical activity, and higher weight loss. The hs-CRP were 1.84 ± 4.61, 1.79 ± 5.01, 2.32 ± 5.32, and 2.82 ± 7.65 mg/L in patients with 0, 1, 2, ≥ 3 PEW parameters, respectively ([Table 2](#T2){ref-type="table"}).

###### Characteristics of 1,834 adults with predialysis CKD based on eGFR stage

![](jkms-32-257-i001)

  Characteristics                       All (n = 1,834)   eGFR stage, mL/min/1.73 m^2^                                                                                   
  ------------------------------------- ----------------- ------------------------------ --------------- --------------- --------------- --------------- --------------- -----------
  Age, yr                               53.9 ± 12.2       43.7 ± 11.9                    50.9 ± 11.6     54.8 ± 11.7     57.2 ± 10.7     57.3 ± 11.0     55.9 ± 11.5     \< 0.001
  Male sex                              60.4              46.8                           65.8            67.6            62.5            60.5            43.0            0.872
  eGFR, mL/min/1.73 m^2^                51 ± 30           110 ± 20                       73 ± 9          52 ± 4          37 ± 4          23 ± 4          12 ± 2          \< 0.001
  24-hr UP, g/day                       1,340 ± 2,137     615 ± 1,103                    723 ± 1,399     1,089 ± 1,829   1,307 ± 1,897   2,092 ± 2,682   2,734 ± 3,199   \< 0.001
  Diabetes                              34.5              15.7                           21.4            30.9            40.7            48.1            50.0            \< 0.001
  Hypertension                          96.1              85.7                           95.3            98.2            98.0            98.6            97.4            \< 0.001
  CVD                                   11.1              3.9                            7.1             11.6            13.8            16.0            8.8             \< 0.001
  Total CO~2~, meq/L                    25.7 ± 3.6        27.8 ± 2.9                     27.7 ± 3.0      26.9 ± 3.0      25.3 ± 3.1      23.6 ± 3.2      21.7 ± 3.3      \< 0.001
  Active smoker                         15.5              16.0                           17.1            18.0            12.8            15.6            11.4            0.163
  Alcohol consumption ³ 2 times/wk      13.0              16.9                           17.4            13.8            12.1            10.3            2.6             \< 0.001
  Physical activity                     38.4              40.8                           48.0            49.2            40.2            35.5            38.4            0.015
  Weight loss \> 3 kg/yr                16.7              12.6                           14.2            15.6            14.6            22.2            23.7            \< 0.001
  WBC, cell/mL                          6,579 ± 1,905     6,248 ± 1,730                  6,377 ± 1,854   6,520 ± 1,889   6,635 ± 1,889   6,972 ± 1,994   6,372 ± 1,952   0.031
  Neutrophil                            58.2 ± 9.0        55.1 ± 9.6                     57.0 ± 8.6      56.7 ± 8.6      58.9 ± 8.7      60.4 ± 8.6      62.2 ± 9.6      \< 0.001
  hs-CRP, mg/L                          2.00 ± 5.23       1.36 ± 4.80                    1.59 ± 3.44     1.98 ± 5.57     1.87 ± 3.99     2.92 ± 7.33     1.71 ± 3.47     0.081
  hs-CRP \> 3 mg/L                      13.6              10.0                           9.7             11.3            15.8            18.7            13.2            \< 0.001
  PEW parameters                                                                                                                                                         
   Serum albumin, g/dL                  4.18 ± 0.42       4.13 ± 0.40                    4.31 ± 0.34     4.20 ± 0.40     4.19 ± 0.37     4.02 ± 0.46     3.97 ± 0.44     \< 0.001
   Serum albumin \< 3.8 g/dL            16.0              9.5                            5.0             14.4            14.1            27.3            31.6            \< 0.001 
   BMI, kg/m^2^                         24.58 ± 3.39      24.04 ± 3.75                   24.76 ± 3.39    24.73 ± 3.28    24.74 ± 3.17    24.50 ± 3.40    24.38 ± 3.51    0.355
   BMI \< 23.0 kg/m^2^                  33.2              42.4                           32.2            29.7            28.6            34.9            37.7            0.321
  UCE, g/day                            1,179 ± 416       1,202 ± 401                    1,308 ± 453     1,243 ± 425     1,163 ± 402     1,088 ± 368     948 ± 341       \< 0.001
   Low quartile of UCE (sex-specific)   25.0              13.9                           19.2            24.4            25.4            34.4            43.0            \< 0.001
   DPI, g/kg/day                        0.80 ± 0.35       0.87 ± 0.28                    0.86 ± 0.33     0.83 ± 0.36     0.81 ± 0.39     0.74 ± 0.36     0.65 ± 0.28     \< 0.001
   DPI \< 0.6 g/kg/day                  26.5              16.5                           20.4            25.7            23.7            34.2            49.1            \< 0.001
   PEW                                  9.0               2.2                            4.4             8.3             6.2             15.6            24.6            \< 0.001

Date are represented as mean ± standard deviation (SD) or percentage (%).

CKD = chronic kidney disease, eGFR = estimated glomerular filtration rate, 24-hr UP = 24-hour urine protein, CVD = cardiovascular disease, WBC = white blood cell, hs-CRP = high sensitivity C-reactive protein, PEW = protein-energy wasting, BMI = body mass index, UCE = urine creatinine excretion, DPI = dietary protein intake.

###### Characteristics of 1,834 adults with predialysis CKD according to numbers of PEW parameters
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  Characteristics                       No. of PEW Parameters                                                   
  ------------------------------------- ----------------------- --------------- --------------- --------------- ----------
  Age, yr                               54.3 ± 11.9             51.9 ± 12.1     55.4 ± 12.6     55.8 ± 11.7     0.069
  Male sex                              69.0                    51.7            58.1            60.0            0.001
  eGFR, mL/min/1.73 m^2^                54 ± 28                 56 ± 34         45 ± 29         34 ± 23         \< 0.001
  24-hr UP, g/day                       975 ± 1,223             1,201 ± 2,065   1,712 ± 2,781   2,579 ± 3,056   \< 0.001
  Diabetes                              31.4                    30.5            41.0            48.5            \< 0.001
  Hypertension                          97.6                    93.5            97.0            97.6            0.799
  CVD                                   8.4                     10.3            15.2            17.0            \< 0.001
  Total CO~2~, meq/L                    26.1 ± 3.4              26.1 ± 3.5      25.2 ± 3.8      23.9 ± 3.6      \< 0.001
  Physical exercise                     49.7                    41.5            37.1            25.4            \< 0.001
  Active smoking                        16.9                    13.9            13.5            19.4            0.842
  Alcohol consumption ≥ 2 times/wk      16.3                    11.3            11.3            9.1             0.003
  Weight loss \> 3 kg/yr                13.5                    17.5            18.7            23.0            0.001
  WBC, cell/mL                          6,628 ± 1,795           6,395 ± 1,930   6,663 ± 2,008   6,870 ± 1,994   0.246
  Neutrophil, %                         56.8 ± 9.1              58.5 ± 8.6      59.2 ± 9.3      61.1 ± 8.6      \< 0.001
  hs-CRP, mg/L                          1.84 ± 4.61             1.79 ± 5.01     2.32 ± 5.32     2.82 ± 7.65     0.021
  hs-CRP \> 3 mg/L                      12.7                    12.1            17.1            15.8            0.067
  PEW parameters                                                                                                
   Serum albumin, g/dL                  4.32 ± 0.28             4.19 ± 0.37     4.07 ± 0.47     3.74 ± 0.56     \< 0.001
   Serum albumin \< 3.8 g/dL            0                       14.7            27.3            63.0            \< 0.001
   BMI, kg/m^2^                         26.22 ± 2.47            23.76 ± 3.37    23.77 ± 3.80    22.46 ± 2.95    \< 0.001
   BMI \< 23.0 kg/m^2^                  0                       49.1            53.2            70.3            \< 0.001
   UCE, g/day                           1,438 ± 389             1,159 ± 321     908 ± 313       756 ± 257       \< 0.001
   Low quartile of UCE (sex-specific)   0                       12.6            65.8            93.9            \< 0.001
   DPI, g/kg/day                        0.95 ± 0.36             0.83 ± 0.31     0.63 ± 0.28     0.48 ± 0.18     \< 0.001
   DPI \< 0.6 g/kg/day                  0                       23.6            53.7            88.5            \< 0.001

Date are represented as mean ± standard deviation (SD) or percentage (%).

CKD = chronic kidney disease, PEW = protein-energy wasting, eGFR = estimated glomerular filtration rate, 24-hr UP = 24-hour urine protein, CVD = cardiovascular disease, WBC = white blood cell, hs-CRP = high sensitivity C-reactive protein, BMI = body mass index, UCE = urine creatinine excretion, DPI = dietary protein intake.

Inflammation, CVD, and PEW
--------------------------

In the study population, 11.1% had CVD, 13.6% had inflammation, and 9.0% had PEW. The prevalence of PEW, inflammation, and CVD according CKD stage was shown in [Fig. 1](#F1){ref-type="fig"}. Among patients with CKD 1 and 2 stages, prevalence was 3.8% for PEW, 9.6% for inflammation, and 4.0% for CVD. Among patient with advanced CKD 4 and 5 stages, prevalence was 17.5% for PEW, 17.9% for inflammation, and 14.5% for CVD. Those who had concurrently PEW, inflammation, and CVD were a small proportion (0.4%), but their proportion increased with advanced CKD stage; 0% (CKD 1 and 2 stages), 0.1% (CKD 3a and 3b stages), and 1.1% (CKD 4 and 5 stages).

![Concurrent prevalence of PEW, I, and CVD in 1,834 adults with predialysis CKD according to eGFR stage. Inflammation is defined as hs-CRP \> 3 mg/L.\
PEW = protein-energy wasting, I = inflammation, CVD = cardiovascular disease, CKD = chronic kidney disease, eGFR = estimated glomerular filtration rate, hs-CRP = high sensitivity C-reactive protein.](jkms-32-257-g001){#F1}

The associated factors of PEW
-----------------------------

We investigated which factors were predictive of PEW among 1,834 adults with predialysis CKD. In multivariate logistic regression models for PEW, male sex, diabetes, higher hs-CRP levels, lower eGFR, lower total CO~2~, and no physical activity were associated with PEW. PEW was independently associated with the inflammatory marker, hs-CRP in univariate (OR, 1.02; 95% CI, 1.01--1.05) and multivariate analyses (OR, 1.03; 95% CI, 1.01--1.06; [Table 3](#T3){ref-type="table"}).

###### Logistic regression analysis model for PEW in 1,834 adults with predialysis CKD
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  Characteristics          Univariate          Multivariate                       
  ------------------------ ------------------- -------------- ------------------- ----------
  Age, yr                  1.02 (1.01--1.03)   0.033          1.00 (0.98--1.02)   0.997
  Male                     0.98 (0.71--1.36)   0.921          1.46 (0.93--2.29)   0.099
  eGFR, mL/min/1.73 m^2^   0.97 (0.96--0.98)   \< 0.001       0.98 (0.96--0.99)   \< 0.001
  Total CO~2~, meq/L       0.86 (0.82--0.91)   \< 0.001       0.93 (0.87--0.99)   0.043
  Physical exercise        0.43 (0.29--0.66)   \< 0.001       0.43 (0.26--0.69)   \< 0.001
  Diabetes                 1.90 (1.38--2.62)   \< 0.001       1.68 (1.09--2.59)   0.02
  Hypertension             0.59 (0.21--1.62)   0.303          1.30 (0.37--4.66)   0.684
  CVD                      1.73 (1.12--2.68)   0.013          1.09 (0.61--1.95)   0.783
  hs-CRP, mg/L             1.02 (1.01--1.05)   0.043          1.03 (1.01--1.06)   0.044

PEW = protein-energy wasting, CKD = chronic kidney disease, OR = odds raito, CI = confidence interval, eGFR = estimated glomerular filtration rate, CVD = cardiovascular disease, hs-CRP = high sensitivity C-reactive protein.

DISCUSSION
==========

As a baseline study of KNOW-CKD, the nutritional status in predialysis CKD adults has been described here. This study demonstrates the prevalence of PEW is increased with advanced CKD stage. The relationships between the nutritional status and inflammatory status and CVD are getting closer in advanced CKD. PEW is associated with metabolic acidosis, low physical activity, comorbid diabetes, and inflammation.

Adverse nutritional changes are serious consequences and a strong indicator of adverse outcomes in CKD. This abnormality is often associated with diminished functional capacity related to uremic metabolic stress ([@B2]). Several terms used to describe the adverse nutritional changes in kidney disease include "uremic malnutrition" ([@B15]), "malnutrition-inflammation atherosclerosis syndrome" ([@B16]), or "malnutrition-inflammation complex syndrome" ([@B17]). Ill-defined terminologies and non-uniform definitions may lead to conceptual errors and data misinterpretation. In 2008, ISRNM experts panel recommended the term "PEW" to describe the state of decreased body stores of protein and energy in CKD patients ([@B4]). The ISRNM proposed that 4 main categories be recognized for diagnosing PEW: biochemical criteria, low body mass, decreased in muscle mass, and low protein intake. Among biochemical indicators, serum albumin is a strong and consistent indicator for PEW. BMI is the most common measure of body mass, and is often used to predict outcomes in CKD. Muscle mass is the most valid criterion for diagnosing PEW, and is often difficult to diagnose low muscle mass. There are no clinical uniform and reproducible measures of muscle mass especially in patients with catabolic status. However, UCE remains the method for assessing total muscle mass because of its lower cost and easier reproducibility. Recent studies ([@B18][@B19]) showed that UCE effectively predicted clinical outcomes in CKD. In the Chronic Renal Insufficient Cohort (CRIC) study ([@B19]), UCE and appendicular muscle mass were modestly correlated. In the NephroTest cohort study ([@B20]), lower gender-specific quartile of UCE was associated with higher risk for mortality in early stage CKD. DPI is a reliable marker of nutritional intake and can be estimated by 24-hour urine urea nitrogen in clinically stable CKD patients ([@B10]). There have been a few studies of nutritional status in predialysis CKD patients using the ISRNM criteria. In this study, we defined the PEW according to the ISRNM criteria, and we described the nutritional status in CKD patients. The prevalence of PEW was 9.0% and was increased with advanced CKD stage.

PEW, inflammation, and CVD clearly contribute to poor outcomes in CKD patients. Persistent, low-grade inflammation has been recognized as a component of CKD. Inflammation plays a contributing role in CVD as well as contributing to PEW. Stenvinkel et al. ([@B5]) reported a strong association between malnutrition, inflammation, and atherosclerosis in 109 patients with terminal chronic renal failure (mean eGFR 7 ± 1 mL/min). The concurrent prevalence of PEW, inflammation, and CVD in their study was 22.0%. They assessed PEW by subjective global assessment (SGA), inflammation by C-reactive protein (CRP) ≥ 10 mg/L, and CVD by the presence of carotid plaque. Another study ([@B6]) suggested that inflammation, malnutrition, and CVD appear to be interrelated, each additionally contributing to high mortality in 128 hemodialysis patients; the concurrent prevalence of PEW, inflammation, and CVD was 23.0%. This study assessed CVD according to CVD history. The Netherlands Co-operative Study on the Adequacy of Dialysis (NECOSAD) study ([@B7]) reported PEW interacted with inflammation and CVD in 815 patients with dialysis. In the NECOSAD study, the concurrent presence of PEW, inflammation, and CVD was a small proportion of 6%, but was strikingly increased the mortality. In our study, we defined PEW according to ISRNM criteria, inflammation as hs-CRP \> 3 mg/L, and CVD as having medical history of CVD. The prevalence of PEW, inflammation, and CVD was 9.0%, 12.7%, and 8.4% respectively, while concurrent presence of PEW, inflammation, and CVD was uncommon (0.4%), but increased with advanced CKD stage. There are possible explanations of the discrepancy between our study and the previous studies. First, non-uniform definitions of PEW, inflammation, and CVD have been assessed in the studies. Second, the study populations of these studies varied in terms of comorbidities and CKD stages.

The mechanisms involved in PEW are multiple and complicated ([@B3]). Although insufficient food intake due to poor appetite and dietary restrictions contribute to PEW, uremia-induced alterations such as increased energy expenditure, persistent inflammation, acidosis, and multiple catabolic endocrine disorders lead to excessive wasting of muscle and fat. We examined the predictors of PEW in 1,834 adults with predialysis CKD. In our multiple adjusted logistic regression models, comorbid diabetes, advanced CKD stage, metabolic acidosis, lack of physical activity, and inflammation were independently associated with PEW. Among the PEW predictors, metabolic acidosis and physical non-exercise are important modifiable factors. Metabolic acidosis induces release of branched-chain amino acids from muscle, also leads to insulin resistance, and induces adrenal glucocorticoid production ([@B21][@B22]). Bicarbonate therapy or low dietary acid load can reduce metabolic acidosis and muscle degradation. Muscle weakness is a reliable marker of poor outcome in CKD and is measured simply by grip strength or gait speed. Exercise-induced benefits include improvement in insulin sensitivity, decrease the muscle degradation, and improvement in cardiovascular functions ([@B23][@B24]). Decreased physical activity likely plays a major role in PEW.

A few considerations are important in the interpretation of our results. First, we sincerely defined the PEW according to ISRNM criteria; however, the cut-off value for each criterion is not validated in our Korean population. Racial differences in nutritional and inflammation status have been observed in CKD patients ([@B25]). Second, our study population is all CKD stage of CKD. Adults with CKD stage 1 and 2 (eGFR \> 60 mL/min/1.73 m^2^) made up 31% of the study population. Third, a single hs-CRP measure may not be a standard method for defining the inflammation in CKD patients. The optimal cut-off value of hs-CRP is also uncertain ([@B13][@B26]). Fourth, there are many risk factors associated with PEW; thus may have an unknown potential bias. However, our study also has several distinct strengths. The KNOW-CKD study has well-designed protocol and is a nationally representative prospective cohort study. We used a rigorous protocol to measure demographics, comorbidities, and laboratory data. We are following the adults with various CKD stage and will evaluate the roll of inflammation, metabolic acidosis, and physical activity in PEW.

In summary, nutritional status in predialysis CKD adults indicated that the prevalence of PEW is about 9.0% according to ISRNM criteria and increased with advanced CKD stage. PEW was associated with metabolic acidosis, low physical activity, comorbid diabetes, and inflammation. Future studies are needed to evaluate the complex interaction between PEW, CVD, and inflammation. New strategies to improve metabolic acidosis or physical activity in at-risk adults with CKD are needed to reduce the burden of CKD.
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